Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q2 2015 · 10-Q
Revenue$273.00K$273.00K+565.9% vs Q2 2014 Net Income-$1.74M-$1.74MN/M vs Q2 2014 EPS Diluted-$0.04-$0.04N/M vs Q2 2014 Operating Income-$1,736,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-635.9%+7220.2 pt vs Q2 2014
Net margin-635.9%+5417.8 pt vs Q2 2014
ended Jan 31, 2015 · filed Mar 4, 2015 · 32 d after period end